SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:oru-93138"
 

Search: onr:"swepub:oai:DiVA.org:oru-93138" > Chronic inflammator...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Chronic inflammatory bowel diseases : studies of microbiota and its influence

Carstens, Adam, 1975- (author)
Örebro universitet,Institutionen för medicinska vetenskaper
Halfvarson, Jonas, professor, 1970- (thesis advisor)
Örebro universitet,Institutionen för medicinska vetenskaper
Engstrand, Lars, professor (thesis advisor)
Karolinska institutet, Stockholm
show more...
Hov, Johannes Espolin Roksund, professor (opponent)
Universitet i Oslo, Oslo universitetssykehus Oslo, Norge
show less...
 (creator_code:org_t)
ISBN 9789175294049
Örebro : Örebro University, 2021
English 133 s.
Series: Örebro Studies in Medicine, 1652-4063 ; 248
  • Doctoral thesis (other academic/artistic)
Abstract Subject headings
Close  
  • Introduction: Inflammatory bowel diseases are becoming increasingly common. The underlying mechanisms are not entirely known but the gut microbiota seem to be involved in the pathogenesis. Aim: The aim of this thesis was to characterise gut microbiota related to diagnosis, disease course and response to biological treatment, taking aspects of the source of biological material into account. Materials and methods: Patients and healthy individuals from several different cohorts in Sweden and Europe were invited. Faecal samples and mucosal biopsies were analysed using different sequencing platforms to investigate the gut microbiota. In Study I the faecal microbiota was correlated to different inflammatory bowel diseases. In Study II we compared the microbiota in faeces to the microbiota in mucosal biopsies. In StudyIII we related the faecal microbiota to the outcome of biological treatment. In Study IV we investigated the diagnostic and prognostic properties of the GAmapTM Dysbiosis Test.Results: The faecal microbiota in collagenous colitis resembles the faecalmicrobiota in inflammatory bowel disease. The faecal microbiota differs from the mucosal microbiota. Faecal microbiota at initiation of biological treatment among patients with Crohn’s disease differ between responders and non-responders. The GAmapTM Dysbiosis Test discriminates patients with inflammatory bowel disease from healthy individuals.Conclusion: Collagenous colitis may share microbial underpinnings with other inflammatory bowel diseases. Conclusions about mucosal interactions with the gut microbiota should be made with caution when usingfaecal samples to characterise the microbiota. In Crohn’s disease, the faecal microbiota may be included in a model to predict the outcome of biological treatment. The GAmap Dysbiosis Test does not seem to be superior to other current diagnostic tools in clinical decision-making. 

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Allmänmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- General Practice (hsv//eng)

Keyword

Inflammatory bowel disease
microscopic colitis
Crohn’s disease
ulcerative colitis
microbiota
microbiome
biological treatment

Publication and Content Type

vet (subject category)
dok (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view